The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome (COVID-19)

The Relationship Between Coronavirus Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.

Study Overview

• Status: Completed
• Conditions: COVID-19; Metabolic Syndrome; Emotional Eating
• Intervention / Treatment: Procedure: A survey form was applied to individuals included in the study face-to-face.

Detailed Description

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects. This study was completed with the descriptive, cross-sectional and relational screening model. The full sampling method was used in the study. The study was completed with 105 individuals with metabolic syndrome attending the diet clinic and 109 healthy individuals without MetS diagnosis also attending the diet clinic. Collection of data used anthropometric measurements and biochemical findings, blood pressure and a survey form, the Coronavirus Anxiety Scale (CAS) and Emotional Eating Scale (EES).

• Study Type: Observational
• Enrollment (Actual): 214

Contacts and Locations

Study Locations

• Turkey
  • Ordu, Turkey, 52000
    • Dilek alemdar

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Power analysis was performed using the G*Power (v3.1.9) program to determine the number of samples. According to Jacob Cohen's effect size coefficients, it was calculated that there should be at least 105 people in the groups for α=0.05 and 1-β=0.95 (95% power) levels, assuming that the evaluations between the two independent groups would have a medium effect size (d=0.5).

Description

Inclusion Criteria:

• The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.

Exclusion Criteria:

• The research included individuals aged 18 years and older, who were pregnant or breastfeeding, with psychological disorder diagnosed by psychiatry, with diagnosis of COVID-19 and using psychiatric medications.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
MetS diagnosis; The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria.	Procedure: A survey form was applied to individuals included in the study face-to-face.; This study was completed with a descriptive, cross-sectional and relational screening model; Other Names: This survey form; Biochemical findings (glucose, HDL, LDL, total cholesterol, triglycerides, CRP, HbA1c, insulin, HOMA-IR).; Blood pressure was measured and recorded.; The coronavirus anxiety scale (CAS) and emotional eating scale (EES) were applied.
non-MetS; The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.	Procedure: A survey form was applied to individuals included in the study face-to-face.; This study was completed with a descriptive, cross-sectional and relational screening model; Other Names: This survey form; Biochemical findings (glucose, HDL, LDL, total cholesterol, triglycerides, CRP, HbA1c, insulin, HOMA-IR).; Blood pressure was measured and recorded.; The coronavirus anxiety scale (CAS) and emotional eating scale (EES) were applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Coronavirus anxiety scale (CAS)	Total points of ≥9 on the scale shows dysfunctional anxiety related to coronavirus.	5 month
Emotional eating scale (EES)	High points on the scale show high levels of emotional eating behavior.	5 month.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
BMI (Body Mass Index)	kg/m^2	5 month.
Glucose	mg/dL	5 month.
Blood pressure	Systolic and diastolic blood pressure	5 month.
HDL	mg/dL	5 month.
LDL	mg/dL	5 month.
triglycerides	mg/dL	5 month.
HbA1c	HbA1c (%)	5 month.
insulin	ng/ml	5 month.
HOMA-IR	index	5 month.
total cholesterol	mg/dL	Through study completion, an average of 5 month.
CRP	mg/dL	5 month.

Collaborators and Investigators

• Sponsor: T.C. ORDU ÜNİVERSİTESİ
• Investigators: Study Director: DİLEK KÜÇÜK ALEMDAR, T.C. ORDU ÜNİVERSİTESİ

Publications and helpful links

General Publications

• Zhang J, Zhang Y, Huo S, Ma Y, Ke Y, Wang P, Zhao A. Emotional Eating in Pregnant Women during the COVID-19 Pandemic and Its Association with Dietary Intake and Gestational Weight Gain. Nutrients. 2020 Jul 28;12(8):2250. doi: 10.3390/nu12082250.

Study record dates

Study Major Dates

• Study Start (Actual): June 20, 2020
• Primary Completion (Actual): November 20, 2020
• Study Completion (Actual): December 12, 2020

Study Registration Dates

• First Submitted: May 30, 2021
• First Submitted That Met QC Criteria: June 2, 2021
• First Posted (Actual): June 3, 2021

Study Record Updates

• Last Update Posted (Actual): June 3, 2021
• Last Update Submitted That Met QC Criteria: June 2, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Keywords: COVID-19; Metabolic Syndrome; Eating
• Additional Relevant MeSH Terms: Pathologic Processes; Glucose Metabolism Disorders; Metabolic Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Disease; Insulin Resistance; Hyperinsulinism; COVID-19; Syndrome; Metabolic Syndrome; Hypoglycemic Agents; Physiological Effects of Drugs; Insulin
• Other Study ID Numbers: KAEK-228

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No